Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Phase III awaiting (ie completed phase II, not yet in III) -- Ignore unavailable to you. Want to Upgrade?

To: QuietWon who wrote (1)	1/30/1999 7:44:00 PM
From: vestor	Read Replies (1) \| Respond to of 32

Believe Cenestin , a premarin equivalent, is in phase three... said to be a $2 billion $ drug..... annual growth rate 15 - 20%.... See DRMD... check Duramed.com...... some say Mar might be the FDA approval month.... at least bears watching....

To: QuietWon who wrote (1)	1/30/1999 11:10:00 PM
From: chalu2	Read Replies (1) \| Respond to of 32

In what city is the upcoming Cruttenden Roth conference???

To: QuietWon who wrote (1)	1/31/1999 1:32:00 AM
From: bob	Read Replies (1) \| Respond to of 32

Check out CLPA cellpathways.com. Their lead off drug, Prevatac, has just completed Phase III human clinical trials for APC (Familial Polyposis, colon polyps that always turn into cancer). Also in phase II/III trials for sporadic colon polyps (28 million cases per year in US), prostate cancer, breast cancer, Barrett's Esophagus (pre-cancerous polyps in esophagus) and lung cancer. This will be $100 by the end of this year, and $2-300 stock by the end of the following year. Have over 200 compounds to create programmed cell death of cancer cells without harming healthy cells, some of which are several thousand times more powerful than Prevatac. There are almost no side effects from Prevatac, a sulfone derivative of sulindac (Clinoral Merck). Merck spent over $15 million to try and accomplish what Cell Pathways has done with drug, but they were not successful. Over 100 patents pending and some just granted. Market for Prevatac in the billions and that is just the beginning. CHECK THIS OUT and do your own DD. Good thread on this company on the Ragingbull.com site.